Clinical Trial Update: Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial of olanzapine in adolescents with schizophrenia or Bipolar I disorder has been completed. The trial was sponsored by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia, Bipolar Disorder | Phase 3 | Status: COMPLETED